* Viveve Medical Inc VIVE.OQ reported a quarterly adjusted
loss
of 67 cents per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 67
cents per share.
* Revenue rose 8.5% to $1.80 million from a year ago;
analysts
expected $1.76 million.
* Viveve Medical Inc's reported EPS for the quarter was a
loss
of 67 cents.
* The mean earnings estimate of analysts had fallen by
about 3.9%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Viveve Medical Inc shares had risen by 15.1% this
quarter and
lost 33.8% so far this year.
* The company reported a quarterly loss of $7.1 million.
* Wall Street's median 12-month price target for Viveve
Medical
Inc is $4.88
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 11
at 09:01 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.67 -0.67 Met
Mar. 31 2022 -0.67 -0.67 Met
Dec. 31 2021 -0.59 -0.72 Missed
Sep. 30 2021 -0.61 -0.67 Missed